Ask the Experts: valuing new pharmaceuticals and sharing this value

18 Mar 2021

Written by Beth Woods (University of York), Danny Palnoch (NHS England and NHS Improvement), Jens Grueger (University of Washington), Patricia Danzon (University of Pennsylvania)

Decision science Health economics Health technology assessment ISPOR Look behind the lecture Medical devices, pharmaceuticals and vaccines Methodology Stakeholder engagement Value assessment

In this ‘Ask the Experts’ feature, we explore some of the challenges associated with valuing new pharmaceuticals, as well as how we may alter how value is shared between stakeholders and whether value should be shared differently between stakeholders across a product’s lifecycle, by posing some key questions to a panel of experts with diverse experiences. Our experts for this instalment, following their participation in an Issue Panel at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 virtual Europe meeting (Virtual ISPOR Europe 2020; 16–19 November), are Patricia Danzon (University of Pennsylvania, PA, USA), Jens Grueger (University of Washington,...